LB Pharma (LBRX): Rega marang dodolan

Tandha merek LB Pharma (LBRX)

LB Pharmaceuticals Inc (LBRX) faces intense pressure from industry behemoths and high risks in developing schizophrenia treatments. To optimize formula discovery, the company is implementing bioinformatics software to automate routine analysis. Research is conducted in in-house laboratories, while the production of trial batches is delegated to contractors. Assessing the company's P/S monitoring on GURU.Markets, we find that determines this parameter level.

lbpharma.us - Multiplikator P/S LBRX (periode 04.07.2022 - 13.11.2026)

Rincian metrik lan analitis perusahaan LB Pharma (LBRX)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega lbpharma.us|LBRX - Bagan rega target
- data kapitalisasi bursa:
Nilai pasar LB Pharma|LBRX - Nilai Total Perusahaan
- data nilai buku modal saham:
Aset Bersih saben Siji Saham LB Pharmaceuticals|LBRX - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku lbpharma.us|LBRX - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Rasio Kabeh Utang marang Dana Pribadi LB Pharmaceuticals Inc|LBRX - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas LB Corp|LBRX - Gunggung utang perusahaan|Rasio utang marang aset resik LB Pharma|LBRX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan LB Pharmaceuticals|Rasio jangkoan perantara lbpharma.us
- rincian asil keuangan lan kelipatan valuasi:
LBRX - Bathi resik perusahaan|Bathi mangsa ngarep LB Pharmaceuticals Inc|LBRX - Pangali P/E|Pangali Forward P/E LB Pharmaceuticals, Inc.|LBRX - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan LB Pharma|LBRX - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan LB Pharmaceuticals|LBRX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan lbpharma.us|LBRX - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep LB Pharmaceuticals Inc
- rincian pendapatan lan dodolan emiten:
LBRX - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan lbpharma.us|LBRX - Multiplikator P/S|Multiplikator forward rega marang pendapatan LB Pharma
Analisis umum perusahaan:lbpharma.us, LBRX
Produk dadi LB Pharmaceuticals, Inc.

Investors utilize multiples to verify an asset's market value relative to its operational success. By analyzing the current P/S ratio of LB Pharmaceuticals Inc (LBRX), you are assessing the ratio of market capitalization to annual sales volume, which is critical for LB Pharmaceuticals Inc (LBRX) as regulatory risks and the anticipation of late-stage clinical trials for its schizophrenia drug are already priced into this market valuation.

Perusahaan pesaing

ALKS (alkermes.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Avadel Pharmaceuticals plc AVDL|atai Life Sciences NV (ATAI) - Rega marang dodolan|GHRS - Rasio rega marang pendapatan|MNMD: Rasio rega marang pendapatan|CMPS: Multiplikator P/S|DRUG (brightmindsbio.com) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan VNDA|CYBN: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Alto Neuro (ANRO)|NRXP: Rasio rega marang dodolan|Multiplikator P/S CING (Cingulate)|Rasio kapitalisasi pasar marang pendapatan SILO|China Pharma - Multiplikator P/S|CMND - Multiplikator P/S|Psyence Biomedical Limited (PBM) - Rasio rega marang pendapatan|SciSparc Corp - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Seelos Therapeutics|Kapitalisasi marang pendapatan Virpax (VRPX)|Multiplikator P/S KRTX